Acelyrin Other Current Liabilities

Acelyrin (SLRN) currently reports a other current liabilities of $3.4M as of March 2025. That compares with $42M in the prior-year period — down 91.9% year over year. Use the charts on this page to explore Acelyrin's other current liabilities history and peer comparisons.

Acelyrin's other current liabilities decreased from $42M to $3.4M — a 91.9% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acelyrin reported $3.4M in other current liabilities as of March 2025. That compares with $42M in the prior-year period — down 91.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $3.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acelyrin, and consider following SLRN for alerts when major investors trade the stock.